Vaccination Utilization and Subnational Inequities during the COVID-19 Pandemic: An Interrupted Time-Series Analysis of Administrative Data across 12 Low- and Middle-Income Countries.
child health
health inequalities
health systems
immunization
routine data
Journal
Vaccines
ISSN: 2076-393X
Titre abrégé: Vaccines (Basel)
Pays: Switzerland
ID NLM: 101629355
Informations de publication
Date de publication:
24 Aug 2023
24 Aug 2023
Historique:
received:
15
02
2023
revised:
31
03
2023
accepted:
17
08
2023
medline:
28
9
2023
pubmed:
28
9
2023
entrez:
28
9
2023
Statut:
epublish
Résumé
During and after the SARS-CoV-2 (COVID-19) pandemic, many countries experienced declines in immunization that have not fully recovered to pre-pandemic levels. This study uses routine health facility immunization data to estimate variability between and within countries in post-pandemic immunization service recovery for BCG, DPT1, and DPT3. After adjusting for data reporting completeness and outliers, interrupted time series regression was used to estimate the expected immunization service volume for each subnational unit, using an interruption point of March 2020. We assessed and compared the percent deviation of observed immunizations from the expected service volume for March 2020 between and within countries. Six countries experienced significant service volume declines for at least one vaccine as of October 2022. The shortfall in BCG service volume was ~6% (95% CI -1.2%, -9.8%) in Guinea and ~19% (95% CI -16%, 22%) in Liberia. Significant cumulative shortfalls in DPT1 service volume are observed in Afghanistan (-4%, 95% CI -1%, -7%), Ghana (-3%, 95% CI -1%, -5%), Haiti (-7%, 95% CI -1%, -12%), and Kenya (-3%, 95% CI -1%, -4%). Afghanistan has the highest percentage of subnational units reporting a shortfall of 5% or higher in DPT1 service volume (85% in 2021 Q1 and 79% in 2020 Q4), followed by Bangladesh (2020 Q1, 83%), Haiti (80% in 2020 Q2), and Ghana (2022 Q2, 75%). All subnational units in Bangladesh experienced a 5% or higher shortfall in DPT3 service volume in the second quarter of 2020. In Haiti, 80% of the subnational units experienced a 5% or higher reduction in DPT3 service volume in the second quarter of 2020 and the third quarter of 2022. At least one region in every country has a significantly lower-than-expected post-pandemic cumulative volume for at least one of the three vaccines. Subnational monitoring of immunization service volumes using disaggregated routine health facility information data should be conducted routinely to target the limited vaccination resources to subnational units with the highest inequities.
Sections du résumé
BACKGROUND
BACKGROUND
During and after the SARS-CoV-2 (COVID-19) pandemic, many countries experienced declines in immunization that have not fully recovered to pre-pandemic levels. This study uses routine health facility immunization data to estimate variability between and within countries in post-pandemic immunization service recovery for BCG, DPT1, and DPT3.
METHODS
METHODS
After adjusting for data reporting completeness and outliers, interrupted time series regression was used to estimate the expected immunization service volume for each subnational unit, using an interruption point of March 2020. We assessed and compared the percent deviation of observed immunizations from the expected service volume for March 2020 between and within countries.
RESULTS
RESULTS
Six countries experienced significant service volume declines for at least one vaccine as of October 2022. The shortfall in BCG service volume was ~6% (95% CI -1.2%, -9.8%) in Guinea and ~19% (95% CI -16%, 22%) in Liberia. Significant cumulative shortfalls in DPT1 service volume are observed in Afghanistan (-4%, 95% CI -1%, -7%), Ghana (-3%, 95% CI -1%, -5%), Haiti (-7%, 95% CI -1%, -12%), and Kenya (-3%, 95% CI -1%, -4%). Afghanistan has the highest percentage of subnational units reporting a shortfall of 5% or higher in DPT1 service volume (85% in 2021 Q1 and 79% in 2020 Q4), followed by Bangladesh (2020 Q1, 83%), Haiti (80% in 2020 Q2), and Ghana (2022 Q2, 75%). All subnational units in Bangladesh experienced a 5% or higher shortfall in DPT3 service volume in the second quarter of 2020. In Haiti, 80% of the subnational units experienced a 5% or higher reduction in DPT3 service volume in the second quarter of 2020 and the third quarter of 2022.
CONCLUSIONS
CONCLUSIONS
At least one region in every country has a significantly lower-than-expected post-pandemic cumulative volume for at least one of the three vaccines. Subnational monitoring of immunization service volumes using disaggregated routine health facility information data should be conducted routinely to target the limited vaccination resources to subnational units with the highest inequities.
Identifiants
pubmed: 37766092
pii: vaccines11091415
doi: 10.3390/vaccines11091415
pmc: PMC10536121
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
BMC Health Serv Res. 2021 Sep 13;21(Suppl 1):547
pubmed: 34511135
BMC Public Health. 2020 Jul 14;20(1):1108
pubmed: 32664849
Front Pediatr. 2022 Aug 11;10:979769
pubmed: 36034563
Front Public Health. 2019 Dec 20;7:392
pubmed: 31921755
Diabetes Metab Syndr. 2020 Nov-Dec;14(6):1809-1814
pubmed: 32956925
Expert Rev Vaccines. 2020 Oct;19(10):899-901
pubmed: 32945213
MMWR Morb Mortal Wkly Rep. 2019 Oct 25;68(42):937-942
pubmed: 31647786
Afr J Reprod Health. 2018 Dec;22(4):113-122
pubmed: 30632728
Lancet. 2021 Aug 7;398(10299):522-534
pubmed: 34273292
MMWR Morb Mortal Wkly Rep. 2021 Oct 29;70(43):1495-1500
pubmed: 34710074
BMC Health Serv Res. 2021 Oct 25;21(Suppl 2):1083
pubmed: 34689787
PLoS One. 2019 Feb 14;14(2):e0212270
pubmed: 30763355
MMWR Morb Mortal Wkly Rep. 2000 Nov 13;69(45):1706-1710
pubmed: 33187395
BMC Res Notes. 2019 Apr 29;12(1):241
pubmed: 31036071
BMJ Glob Health. 2019 Sep 29;4(5):e001849
pubmed: 31637032
Vaccines (Basel). 2020 Sep 22;8(3):
pubmed: 32972015
Hum Vaccin Immunother. 2021 Mar 4;17(3):661-663
pubmed: 32991237
BMC Public Health. 2018 Aug 2;18(1):952
pubmed: 30071824
Vaccines (Basel). 2018 Apr 10;6(2):
pubmed: 29642596
Front Pediatr. 2022 Mar 29;10:774281
pubmed: 35425724
MMWR Morb Mortal Wkly Rep. 2014 Nov 21;63(46):1055-8
pubmed: 25412062
J Infect Dev Ctries. 2022 Nov 29;16(11):1687-1695
pubmed: 36449639
Vaccine. 2020 Jan 3;38(1):63-69
pubmed: 31615717
Bull World Health Organ. 2009 Jul;87(7):535-41
pubmed: 19649368
Vaccines (Basel). 2019 Mar 08;7(1):
pubmed: 30857257
Nat Hum Behav. 2021 Apr;5(4):529-538
pubmed: 33686204
Pan Afr Med J. 2017 Jun 21;27(Suppl 3):6
pubmed: 29296141
Int J Environ Res Public Health. 2021 Jan 22;18(3):
pubmed: 33499422
J Infect. 2022 Oct;85(4):436-480
pubmed: 35914610
BMJ Paediatr Open. 2020 Nov 2;4(1):e000842
pubmed: 33195821
BMC Health Serv Res. 2021 Sep 13;21(Suppl 1):512
pubmed: 34511080
PLoS Med. 2022 Aug 30;19(8):e1004070
pubmed: 36040910
Arch Public Health. 2018 Nov 19;76:67
pubmed: 30473789
PLoS One. 2021 Feb 17;16(2):e0246951
pubmed: 33596271
Vaccine. 2022 Jan 3;40(1):141-150
pubmed: 34794824
Vaccine. 2018 Nov 26;36(49):7549-7555
pubmed: 30366805
Ann Med Surg (Lond). 2022 Sep 10;82:104613
pubmed: 36124222
Lancet Glob Health. 2022 Feb;10(2):e186-e194
pubmed: 34951973
Health Policy Plan. 2011 Jul;26 Suppl 1:i4-12
pubmed: 21729916
Lancet Infect Dis. 2022 May;22(5):595
pubmed: 35460657
BMC Public Health. 2018 Mar 6;18(1):324
pubmed: 29510684
Vaccine. 2020 Oct 21;38(45):7146-7155
pubmed: 32943265
Philos Trans R Soc Lond B Biol Sci. 2014 May 12;369(1645):20130433
pubmed: 24821919
Proc Natl Acad Sci U S A. 2014 Aug 26;111(34):12288-93
pubmed: 25136130